Literature DB >> 27570777

Metastatic signet ring cell carcinoma of unknown primary origin: a case report and review of the literature.

Ahmad Al-Taee1, Rawaa Almukhtar1, Jinping Lai2, Bassel Jallad3.   

Abstract

In spite of the increasingly sophisticated diagnostic workup, detailed investigations fail to reveal a primary site of origin for about 3-5% of metastatic tumors. The most commonly reported subtype in cancer of unknown primary origin is adenocarcinoma. Signet ring cell carcinoma (SRCC) is a rare poorly differentiated aggressive subtype of adenocarcinoma that most commonly arise from the gastrointestinal tract. It usually presents late and is associated with poor prognosis. Treatment options remain limited to anecdotal reports. However, immunohistochemical studies can be useful in suggesting an origin and therefore may help guide investigations and treatment options. Here we present an unusual case of metastatic SRCC of unknown primary origin presenting as peritoneal carcinomatosis in a 73-year-old man. We also review the literature on metastatic SRCC of unknown primary origin and discuss the relevant findings. This work highlights the importance of collaboration between clinicians and pathologists as well as detailed histopathological, immunohistochemical, and molecular analyses which can help guide investigations and management options.

Entities:  

Keywords:  Signet ring cell carcinoma (SRCC); neoplasm metastasis; peritoneal neoplasms; unknown primary

Year:  2016        PMID: 27570777      PMCID: PMC4980384          DOI: 10.21037/atm.2016.07.24

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  11 in total

1.  Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.

Authors:  J Heidemann; H R Gockel; G Winde; H Herbst; W Domschke; N Lügering
Journal:  Z Gastroenterol       Date:  2002-01       Impact factor: 2.000

2.  Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.

Authors:  Chika Kusakari; Hiroshi Soda; Yoichi Nakamura; Hiroyuki Yamaguchi; Takeshi Kitazaki; Hirofumi Nakano; Yuichi Matsubara; Tomayoshi Hayashi; Toshiya Nagasaki; Takeshi Nagayasu; Shigeru Kohno
Journal:  Lung Cancer       Date:  2007-01-08       Impact factor: 5.705

3.  Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Authors:  John D Hainsworth; Mark S Rubin; David R Spigel; Ralph V Boccia; Samuel Raby; Raven Quinn; F Anthony Greco
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

4.  Molecular classification of human carcinomas by use of gene expression signatures.

Authors:  A I Su; J B Welsh; L M Sapinoso; S G Kern; P Dimitrov; H Lapp; P G Schultz; S M Powell; C A Moskaluk; H F Frierson; G M Hampton
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

5.  Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon.

Authors:  Peiguo G Chu; Lawrence M Weiss
Journal:  Am J Clin Pathol       Date:  2004-06       Impact factor: 2.493

6.  Metastatic signet-ring cell carcinoma of unknown primary origin.

Authors:  C Gregoire; G Muller; J-P Machiels; J-C Goeminne
Journal:  Acta Clin Belg       Date:  2014-04       Impact factor: 1.264

7.  Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.

Authors:  Gauri R Varadhachary; Martin N Raber; Aurelio Matamoros; James L Abbruzzese
Journal:  Lancet Oncol       Date:  2008-06       Impact factor: 41.316

8.  Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.

Authors:  T Tot
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

9.  Primary peritoneal serous carcinoma with signet ring cells.

Authors:  Yanru Hou; Yi Li; Danhua Shen; Heng Cui
Journal:  Gynecol Oncol Case Rep       Date:  2011-10-11

Review 10.  Microangiopathic hemolytic anemia as the first manifestation of metastatic signet ring cell carcinoma of unknown origin: a case report and review of literature.

Authors:  Sang-Yong Shin; Hyosoon Park; Seoung Wan Chae; Hee-Yeon Woo
Journal:  Korean J Lab Med       Date:  2011-06-28
View more
  3 in total

1.  Signet Ring Cell Carcinoma of Unknown Primary Origin Detected Incidentally by Lymph Node Purification for Thyroid Carcinoma.

Authors:  Hideo Handa; Daisuke Gomi; Toshirou Fukushima; Takashi Kobayashi; Nodoka Sekiguchi; Akiyuki Sakamoto; Yoshiko Tsukahara; Hirohide Matsushita; Shigeru Sasaki; Keiko Mamiya; Tomonobu Koizumi; Takashi Ichiyama
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

2.  A Rare Case of Signet Ring Cell Colon Cancer Presenting as Adult Colorectal Intussusception.

Authors:  D A Gaskin; A Reid; M O'Shea; P S Gaskin
Journal:  Case Rep Pathol       Date:  2022-02-08

3.  Signet-ring cell adenocarcinoma of unknown primary presenting with superior vena cava (SVC) syndrome: rare type of cancer.

Authors:  Ramon Bagaporo Larrazabal; Paula Victoria Catherine Cheng; Aileen David-Wang; Daryl Requiso
Journal:  BMJ Case Rep       Date:  2019-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.